爱得科技成功过会北交所 骨科耗材龙头开启资本新征程

Group 1 - The core viewpoint of the article is that Suzhou Aide Technology Development Co., Ltd. has successfully passed the initial public offering (IPO) review by the Beijing Stock Exchange, marking a significant step towards its entry into the capital market as the 79th company to do so this year [2] - Aide Technology is a leading enterprise in the orthopedic medical device sector, with its main business covering spinal, trauma, sports medicine orthopedic consumables, and wound repair products, which are widely used in various medical institutions [2] - The listing committee of the Beijing Stock Exchange focused on the impact of centralized procurement policies on performance and the authenticity of distribution revenue during the review process, and the company provided detailed data and compliance explanations to gain regulatory approval [2] Group 2 - The company plans to publicly issue no less than 1 million shares and no more than 29.530762 million shares, raising 197 million yuan, which will be primarily invested in expanding orthopedic consumables production, building a research and development center, and upgrading the marketing network [2] - In the context of increasing orthopedic medical demand driven by an aging population, the implementation of the fundraising projects will further expand the company's production capacity, strengthen its technological research and development advantages, and improve its national marketing layout, injecting momentum for sustained performance growth [2]